Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 62.1 TWD 0.16% Market Closed
Market Cap: 10.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

P/OCF
Price to OCF

-7.9
Current
-7.2
Median
22.1
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-7.9
=
Market Cap
10.2B TWD
/
Operating Cash Flow
-1.3B TWD
All Countries
Close
Market Cap P/OCF
KY
Tanvex BioPharma Inc
TWSE:6541
10.2B TWD -7.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 092.3
US
Abbvie Inc
NYSE:ABBV
314.6B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 19.5
US
Gilead Sciences Inc
NASDAQ:GILD
117.3B USD 11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.4B USD -125
US
Epizyme Inc
F:EPE
94.1B EUR -470.5
AU
CSL Ltd
ASX:CSL
136.4B AUD 30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -76
NL
argenx SE
XBRU:ARGX
36.2B EUR -145.4
 
KY
Tanvex BioPharma Inc
TWSE:6541
Average P/OCF: 19.9
Negative Multiple: -7.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 092.3
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
19.5
US
Gilead Sciences Inc
NASDAQ:GILD
11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -125
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.5
AU
CSL Ltd
ASX:CSL
30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -76
NL
argenx SE
XBRU:ARGX
Negative Multiple: -145.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More